LEIDOS BIOMEDICAL RESEARCH, INC.
DCEG- GWAS Studies
DCEG- GWAS Studies is a funding opportunity from LEIDOS BIOMEDICAL RESEARCH, INC., up to 1077448, closing August 30, 2026.
Aug 30, 2026
(30d left)Overview
The Cancer Genetic Markers of Susceptibility (CGEMS) project began in 2005 as a 3-year pilot study to identify inherited genetic susceptibility to prostate and breast cancer (cgems.cancer.gov). CGEMS has developed into a robust research program involving genome-wide association studies (GWASs) for dozens of different…